| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
Submitted on December 12, 2005
Accepted on July 13, 2006
Department of Pediatrics "F. Fede" Seconda Università degli Studi di Napoli, Via Luigi De Crecchio 2, 80138, Napoli
* To whom correspondence should be addressed. E-mail: emanuele.miraglia{at}unina2.it.
Objective: The insulin VNTR polymorphism located in the insulin gene promoter (INS VNTR) has been associated with insulin levels in obese children. Hyperinsulinemia is a pivotal factor in the development of metabolic syndrome, an emerging complicance in childhood obesity. With the present study we aimed to test the associations between INS VNTR and the metabolic syndrome in juvenile-onset obesity.
Materials and Methods: We screened for the INS VNTR 320 obese children (152 girls; mean age 11.2 ± 2.3 yr; mean z-score BMI 3.6 ± 1.1). All of them underwent a standard oral glucose tolerance test (OGTT); baseline measurements included blood pressure, plasma lipid and fasting insulin levels. By using the data derived from the OGTT, the whole body insulin sensitivity (WBISI) and the insulinogenic index (IGI) were calculated.
Results: The prevalence of metabolic syndrome reached 39 percent. No differences in INS VNTR genotype distribution were observed between obese subjects and two hundred lean, age and sex matched, children (P = 0.7). Among obeses, the prevalence of the metabolic syndrome was significantly higher in subjects with the I/I genotype (P = 0.006); the risk for developing the metabolic syndrome was significantly higher in subjects carrying the I/I genotype (OR: 2.5; 95% CI: 1.5-3.9). Obese subjects homozygotes for the class I allele showed higher insulin levels, and IGI, but lower WBISI.
Conclusions: We conclude that the I variant of the insulin promoter, when expressed in homozygosis, can predispose obese children to develop the metabolic syndrome.
This article has been cited by other articles:
 |
|
 |
|
  C. Le Stunff, A. Dechartres, V. Mariot, C. Lotton, C. Trainor, E. Miraglia Del Giudice, D. Meyre, I. Bieche, I. Laurendeau, P. Froguel, et al. Association Analysis Indicates That a Variant GATA-Binding Site in the PIK3CB Promoter Is a Cis-Acting Expression Quantitative Trait Locus for This Gene and Attenuates Insulin Resistance in Obese Children Diabetes, February 1, 2008; 57(2): 494 - 502. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Le Stunff, A. Dechartres, E. Miraglia Del Giudice, P. Froguel, and P. Bougneres A Single-Nucleotide Polymorphism in the p110 Gene Promoter Is Associated with Partial Protection from Insulin Resistance in Severely Obese Adolescents J. Clin. Endocrinol. Metab., January 1, 2008; 93(1): 212 - 215. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. O Mook-Kanamori, J J Miranda Geelhoed, E. A P Steegers, J. C M Witteman, A. Hofman, H. A Moll, C. M van Duijn, A. C S Hokken-Koelega, and V. W V Jaddoe Insulin gene variable number of tandem repeats is not associated with weight from fetal life until infancy: the Generation R Study Eur. J. Endocrinol., December 1, 2007; 157(6): 741 - 748. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Bougneres Genotypic and phenotypic complexity at the insulin variable number of tandem repeats locus. J. Clin. Endocrinol. Metab., November 1, 2006; 91(11): 4246 - 4249. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |
